Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | SRC | P12931 | 1/20 | 0.44 |
| ▸ | CETP | P11597 | 3/20 | 0.44 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.37 |
| ▸ | MTOR | P42345 | 1/20 | 0.37 |
| ▸ | ALPG | P10696 | 1/20 | 0.37 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.37 |
| ▸ | IDO1 | P14902 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3624069 | 0.83 | AOX1 (0.50) | TSHRSRCCETPFOLH1ALDH1A1 | |
| SCHEMBL922111 | 0.83 | RAB9A (0.40) | ALDH1A1KDM4EMAOBIDO1 | |
| SCHEMBL14439909 | 0.81 | TSHR (0.55) | TSHRSRCCETPFOLH1ALDH1A1 | |
| SCHEMBL12567320 | 0.79 | TSHR (0.57) | TSHRSRCCETPFOLH1ALDH1A1 | |
| SCHEMBL13185883 | 0.79 | TSHR (0.57) | TSHRSRCCETPFOLH1ALDH1A1 | |
| SCHEMBL17170447 | 0.78 | TSHR (0.55) | TSHRSRCCETPFOLH1ALDH1A1 | |
| SCHEMBL389180 | 0.77 | TSHR (0.63) | TSHRSRCCETPFOLH1ALDH1A1 | |
| SCHEMBL3367142 | 0.77 | TSHR (0.63) | TSHRSRCCETPFOLH1ALDH1A1 | |
| SCHEMBL13896611 | 0.76 | TSHR (0.53) | TSHRCETPFOLH1ALDH1A1 | |
| SCHEMBL26361302 | 0.76 | TSHR (0.53) | TSHRSRCCETPFOLH1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2138502-B1 | PROCESS FOR PRODUCING PHOSPHORUS-CONTAINING DEHYDROAMINO ACID | MEIJI SEIKA PHARMA CO LTD (JP) | 2014-02-19 | — | — | EP | disclosed |
| US-8329935-B2 | Process for producing phosphorus-containing dehydroamino acid | MEJI SEIKA KAISHA LTD. (JP) | 2012-12-11 | — | — | US | disclosed |
| US-20110009662-A1 | PROCESS FOR PRODUCING PHOSPHORUS-CONTAINING DEHYDROAMINO ACID | MEIJI SEIKA KAISHA LTD. (JP) | 2011-01-13 | — | — | US | disclosed |
| EP-2138502-A1 | PROCESS FOR PRODUCING PHOSPHORUS-CONTAINING DEHYDROAMINO ACID | Meiji Seika Kaisha Ltd. (JP) | 2009-12-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110009662-A1 | PROCESS FOR PRODUCING PHOSPHORUS-CONTAINING DEHYDROAMINO ACID | AMPD2, AMPD1, AMPD3 | TSHR 2147/4885SRC 3364/4885CETP 2989/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.